CDNA CareDx Inc

Price (delayed)

$88.15

Market cap

$4.34B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.46

Enterprise value

$4.14B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

The equity has soared by 175% YoY and by 3% from the previous quarter
CDNA's gross profit has surged by 57% year-on-year and by 15% since the previous quarter
The company's quick ratio has surged by 101% YoY but it fell by 6% QoQ
CareDx's net income has decreased by 5% from the previous quarter but it has increased by 4.6% YoY
CareDx's EPS has decreased by 4.5% from the previous quarter

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
49.26M
Market cap
$4.34B
Enterprise value
$4.14B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
16.07
Price to sales (P/S)
25.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
24.47
Earnings
Revenue
$169.37M
EBIT
-$21.35M
EBITDA
-$12.23M
Free cash flow
$17.27M
Per share
EPS
-$0.46
Free cash flow per share
$0.35
Book value per share
$5.49
Revenue per share
$3.46
TBVPS
$5.83
Balance sheet
Total assets
$353.55M
Total liabilities
$84.91M
Debt
$16.54M
Equity
$268.64M
Working capital
$196.24M
Liquidity
Debt to equity
0.06
Current ratio
4.14
Quick ratio
3.92
Net debt/EBITDA
16.15
Margins
EBITDA margin
-7.2%
Gross margin
66.4%
Net margin
-11.8%
Operating margin
-14.8%
Efficiency
Return on assets
-7.9%
Return on equity
-10.9%
Return on invested capital
-78.5%
Return on capital employed
-7.3%
Return on sales
-12.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
1.52%
1 week
9.15%
1 month
29.84%
1 year
282.26%
YTD
21.67%
QTD
21.67%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$169.37M
Gross profit
$112.42M
Operating income
-$25.01M
Net income
-$19.98M
Gross margin
66.4%
Net margin
-11.8%
CDNA's gross profit has surged by 57% year-on-year and by 15% since the previous quarter
The revenue has increased by 48% YoY and by 13% QoQ
The net margin has grown by 36% year-on-year and by 7% since the previous quarter
CareDx's operating margin has increased by 24% YoY and by 23% from the previous quarter

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
16.07
P/S
25.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
24.47
CareDx's EPS has decreased by 4.5% from the previous quarter
The equity has soared by 175% YoY and by 3% from the previous quarter
The stock's price to book (P/B) is 106% more than its last 4 quarters average of 7.8 and 94% more than its 5-year quarterly average of 8.3
The price to sales (P/S) is 187% more than the last 4 quarters average of 8.9
The revenue has increased by 48% YoY and by 13% QoQ

Efficiency

How efficient is CareDx business performance
The ROIC has soared by 86% YoY and by 20% QoQ
The ROE has soared by 50% YoY and by 20% from the previous quarter
CDNA's return on assets is up by 48% year-on-year and by 17% since the previous quarter
CareDx's ROS has increased by 37% YoY and by 11% from the previous quarter

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
The company's total assets has surged by 144% YoY and by 2.6% QoQ
The company's quick ratio has surged by 101% YoY but it fell by 6% QoQ
The debt is 94% smaller than the equity
The equity has soared by 175% YoY and by 3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.